Page 132 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

108 F. David Carmona, Ana Márquez, Javier Martín et al.

[6] Fietta, P., Manganelli, P., Zanetti, A., et al. Familial giant cell arteritis and polymyalgia
rheumatica: aggregation in 2 families. J. Rheumatol. 2002; 29:1551-1555.

[7] Bartolome, M. J., Martinez-Taboda, V. M., Lopez-Hoyos, M., et al. Familial
aggregation of polymyalgia rheumatica and giant cell arteritis: genetic and T cell
repertoire analysis. Clin. Exp. Rheumatol. 2001; 19:259-264.

[8] Liang, G. C., Simkin, P. A., Hunder, G. G., et al. Familial aggregation of polymyalgia
rheumatica and giant cell arteritis. Arthritis Rheum. 1974; 17:19-24.

[9] Granato, J. E., Abben, R. P., May, W. S. Familial association of giant cell arteritis. A
case report and brief review. Arch. Intern. Med. 1981; 141:115-117.

[10] Mathewson, J. A., Hunder, G. G. Giant cell arteritis in two brothers. J. Rheumatol.
1986; 13:190-192.

[11] Gros, F., Maillefert, J. F., Behin, A., et al. Giant cell arteritis with ocular complications
discovered simultaneously in two sisters. Clin. Rheumatol. 1998; 17:58-61.

[12] Raptis, L., Pappas, G., Akritidis, N. Horton's three sisters: familial clustering of
temporal arteritis. Clin. Rheumatol. 2007; 26:1997-1998.

[13] Carmona, F. D., Gonzalez-Gay, M. A., Martin, J. Genetic component of giant cell
arteritis. Rheumatology (Oxford) 2014; 2014; 53:6-18.

[14] Armstrong, R. D., Behn, A., Myles, A., et al. Histocompatibility antigens in
polymyalgia rheumatica and giant cell arteritis. J. Rheumatol. 1983; 10:659-661.

[15] Jacobsen, S., Baslund, B., Madsen, H. O., et al. Mannose-binding lectin variant alleles
and HLA-DR4 alleles are associated with giant cell arteritis. J. Rheumatol. 2002; 29:
2148-2153.

[16] Bignon, J. D., Ferec, C., Barrier, J., et al. HLA class II genes polymorphism in DR4
giant cell arteritis patients. Tissue Antigens 1988; 32:254-258.

[17] Richardson, J. E., Gladman, D. D., Fam, A., et al. HLA-DR4 in giant cell arteritis:
association with polymyalgia rheumatica syndrome. Arthritis Rheum. 1987; 30:1293-
1297.

[18] Bignon, J. D., Barrier, J., Soulillou, J. P., et al. HLA DR4 and giant cell arteritis. Tissue
Antigens 1984; 24:60-62.

[19] Lowenstein, M. B., Bridgeford, P. H., Vasey, F. B., et al. Increased frequency of HLA-
DR3 and DR4 in polymyalgia rheumatica-giant cell arteritis. Arthritis Rheum. 1983; 26:
925-927.

[20] Barrier, J., Bignon, J. D., Soulillou, J. P., et al. Increased prevalence of HLA-DR4 in
giant-cell arteritis. N. Engl. J. Med. 1981; 305:104-105.

[21] Combe, B., Sany, J., Le Quellec, A., Clot, J., Eliaou, J. F. Distribution of HLA-DRB1
alleles of patients with polymyalgia rheumatica and giant cell arteritis in a
Mediterranean population. J. Rheumatol. 1998; 25:94-98.

[22] Dababneh, A., Gonzalez-Gay, M. A., Garcia-Porrua, C., et al. Giant cell arteritis and
polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II
association. J. Rheumatol. 1998; 25:2140-2145.

[23] Martinez-Taboda, V. M., Bartolome, M. J., Lopez-Hoyos, M., et al. HLA-DRB1 allele
distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical
subgroups and prognosis. Semin. Arthritis Rheum. 2004; 34:454-464.

[24] Rauzy, O., Fort, M., Nourhashemi, F., et al. Relation between HLA DRB1 alleles and
corticosteroid resistance in giant cell arteritis. Ann. Rheum. Dis. 1998; 57:380-382.

Complimentary Contributor Copy